AA
AZN icon

Ancora Advisors’s AstraZeneca AZN Stock Holding History

Ancora Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Sell
1,535
-92
-6% -$17.7K 0.01% 623
2025
Q4 		$299K Buy
1,627
+1,010
+164% +$177K 0.01% 641
2025
Q3 		$94.6K Buy
617
+19
+3% +$2.88K ﹤0.01% 880
2025
Q2 		$83.6K Buy
598
+23
+4% +$3.22K ﹤0.01% 914
2025
Q1 		$84.5K Sell
575
-25
-4% -$3.62K ﹤0.01% 902
2024
Q4 		$78.6K Buy
600
+25
+4% +$3.5K ﹤0.01% 905
2024
Q3 		$89.5K Hold
575
– – ﹤0.01% 850
2024
Q2 		$89.6K Sell
575
-292
-34% -$43.9K ﹤0.01% 816
2024
Q1 		$117K Buy
867
+2
+0.2% +$265 ﹤0.01% 777
2023
Q4 		$117K Hold
865
– – ﹤0.01% 777
2023
Q3 		$117K Sell
865
-61
-7% -$8.33K ﹤0.01% 761
2023
Q2 		$132K Buy
926
+11
+1% +$1.62K ﹤0.01% 734
2023
Q1 		$127K Buy
915
+52
+6% +$7K ﹤0.01% 734
2022
Q4 		$117K Sell
863
-150
-15% -$18.8K ﹤0.01% 790
2022
Q3 		$111K Buy
1,013
+108
+12% +$13.7K ﹤0.01% 871
2022
Q2 		$120K Sell
905
-193
-18% -$25.3K ﹤0.01% 905
2022
Q1 		$146K Hold
1,098
– – ﹤0.01% 902
2021
Q4 		$128K Hold
1,098
– – ﹤0.01% 949
2021
Q3 		$132K Sell
1,098
-52
-5% -$6.05K ﹤0.01% 900
2021
Q2 		$138K Hold
1,150
– – ﹤0.01% 833
2021
Q1 		$114K Buy
1,150
+52
+5% +$5.23K ﹤0.01% 844
2020
Q4 		$110K Sell
1,098
-969
-47% -$103K ﹤0.01% 733
2020
Q3 		$227K Buy
2,067
+654
+46% +$72.7K 0.01% 584
2020
Q2 		$149K Buy
1,413
+344
+32% +$35.5K 0.01% 639
2020
Q1 		$95K Hold
1,069
– – ﹤0.01% 786
2019
Q4 		$107K Buy
+1,069
New +$101K ﹤0.01% 763
2018
Q4 		– Sell
-1,069
Closed -$85K – 653
2018
Q3 		$85K Buy
+1,069
New +$80.9K ﹤0.01% 791
2017
Q1 		– Sell
-302
Closed -$16K – 644
2016
Q4 		$16K Buy
+302
New +$17.1K ﹤0.01% 978

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Ancora Advisors's AZN Position: Q1 2026 in Review

Ancora Advisors reduced its AstraZeneca (AZN) stake by 5.7% in Q1 2026, selling an estimated $17.7K and leaving 1,535 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #623.

Ancora Advisors first reported a position in AZN in Q4 2016 and has held it in 28 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Ancora Advisors held 1,535 shares of AstraZeneca worth $303K as of Q1 2026.
  • Ancora Advisors sold 92 AstraZeneca shares in Q1 2026, an estimated $17.7K.
  • AstraZeneca made up 0.01% of Ancora Advisors's portfolio in Q1 2026, its #623 holding.
  • Ancora Advisors first reported a position in AstraZeneca in Q4 2016 and has held it in 28 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.